Qi L, Robinson WA, Brady BMR, Singh R, and Glodé LM: Relationship between expression of VEGF and its receptors to migration and invasion of human prostate cancer cells in vitro. Anticancer Research 23(5A): 3917-22, 2003.
Tyagi AK, Agarwal C, Singh RP, Shroyer KR, Glodé LM,and Agarwal R: Silibinin down-regulates survivin protein and mRNA expression and causes caspases activation and apoptosis in human bladder transitional-cell papilloma RT4 cells. Biochemical and Biophysical Research Communications 312: 1178-1184, 2003.
Qi L, Nett TM, Allen MC, Sha X, Harrison GS, Frederick BA, Crawford ED, and Glodé LM: Binding and cytotoxicity of conjugated and recombinant fusion proteins targeted to the GnRH receptor. Cancer Research 64: 2090-2095, 2004.
Fung KY, Glodé LM, Green S, and Duncan M: A comprehensive characterization of the peptide and protein constitutents of human seminal fluid. The Prostate 61(2): 171-181, 2004.
Ziada A, Barqawi A, Glode LM, Varella-Garcia M, Crighton F, Majeski S, Rosenblum M, Kane M, Chen L, and Crawford ED: The use of trastuzumab in the treatment of hormone refractory prostate cancer; phase II trial. Prostate. 60(4): 332-337, 2004.
Tyagi A, Agarwal C, Harrison G, Glodé LM, and Agarwal R: Silibinin causes cell cycle arrest in human bladder transitional cell carcinoma cells by regulating
Latest Publications in PubMed